IL6 and hepatocellular carcinoma: The functional polymorphisms located in the APOBEC3B promoter (rs2267401-G) and UNG enhancer (rs3890995-C) predispose the IL-6 induced APOBEC3B-UNG imbalance and increase the risk of HCC (10).